Aura Biosciences, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Sep 2020 | — | — | $11.3M |
| Dec 2020 | $2.7M | $22.1M | $17.4M |
| Mar 2021 | — | — | $99.7M |
| Jun 2021 | — | — | $92.2M |
| Sep 2021 | $6.4M | $90.7M | $81.8M |
| Dec 2021 | $7.7M | $160.0M | $149.1M |
| Mar 2022 | $5.3M | $146.4M | $108.4M |
| Jun 2022 | $5.9M | $135.0M | $53.8M |
| Sep 2022 | $28.1M | $143.1M | $61.1M |
| Dec 2022 | $28.4M | $223.9M | $121.6M |
| Mar 2023 | $25.8M | $206.0M | $38.5M |
| Jun 2023 | $26.3M | $192.7M | $47.7M |
| Sep 2023 | $28.0M | $179.8M | $55.6M |
| Dec 2023 | $29.2M | $255.1M | $41.1M |
| Mar 2024 | $26.2M | $235.0M | $26.3M |
| Jun 2024 | $26.8M | $218.3M | $30.1M |
| Sep 2024 | $30.7M | $205.3M | $25.4M |
| Dec 2024 | $30.5M | $182.5M | $31.7M |
| Mar 2025 | $27.4M | $155.4M | $38.2M |
| Jun 2025 | $29.8M | $204.4M | $107.4M |
| Sep 2025 | $33.4M | $190.0M | $47.6M |
| Dec 2025 | $32.5M | $169.4M | $59.5M |
| Mar 2026 | $30.4M | $137.7M | $84.8M |
| Jun 2026 | $32.9M | $348.1M | $67.8M |